Glucose metabolic disorder in Klinefelter syndrome: a retrospective analysis in a single Chinese hospital and literature review
We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyp...
Saved in:
Published in | BMC endocrine disorders Vol. 21; no. 1; pp. 239 - 10 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
01.12.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia.
This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia.
We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of β-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group.
KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms. |
---|---|
AbstractList | We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia.
This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia.
We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of β-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group.
KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms. We aimed to investigate the clinical characteristics and islet [beta]-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia. We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of [beta]-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group. KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms. Background We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. Methods This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia. Results We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of β-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group. Conclusions KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms. Background We aimed to investigate the clinical characteristics and islet [beta]-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. Methods This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia. Results We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of [beta]-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group. Conclusions KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms. Keywords: Klinefelter syndrome, Diabetes mellitus, Hyperglycemia, Insulin resistance, Hypoglycemic therapy Abstract Background We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. Methods This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia. Results We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of β-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group. Conclusions KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms. We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia.BACKGROUNDWe aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia.This is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia.METHODSThis is a retrospective study. In total, 22 patients diagnosed with KS were identified from the electronic medical record system, including 9 patients with hyperglycemia (total patients with hyperglycemia, THG-KS group) and 5 hyperglycemic KS patients with oral glucose tolerance test (OGTT) results (HG-KS group). An additional 5 subjects with hyperglycemia and 5 normal glucose tolerance (NGT) subjects matched based on body mass index were included as the HG group and NGT group, respectively. Data from clinical and laboratory examinations were collected. We further performed a literature review of KS and hyperglycemia.We found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of β-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group.RESULTSWe found that KS patients developed abnormal glucose metabolism earlier in life than those without KS, and the median age was 17 years, ranging from 10 years to 19 years. Six of 17 (35.3%) patients were diagnosed with diabetes mellitus and 3 of 17 (17.6%) patients were diagnosed with prediabetes. Among 10 patients with both fasting blood glucose and insulin results recorded, there were 8 out of 17 (47.1%) KS patients had insulin resistance. The prevalence of hypertension and dyslipidemia was higher in patients with hyperglycemia and KS than in patients with NGT KS. Compared with the HG group, insulin sensitivity levels were lower in HG-KS group, whereas homeostasis model assessment of β-cell function levels (p = 0.047) were significantly, indicating higher insulin secretion levels in the HG-KS group.KS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms.CONCLUSIONSKS patients develop hyperglycemia earlier in life than those without KS and show lower insulin sensitivity and higher insulin secretion. These patients also have a higher prevalence of other metabolic diseases and may have different frequencies of developing KS-related symptoms. |
ArticleNumber | 239 |
Audience | Academic |
Author | Liu, Shixuan Song, Shuoning Yuan, Tao Wang, Linjie Chen, Shi Dong, Yingyue Zhao, Weigang Tang, Yan Fu, Yong |
Author_xml | – sequence: 1 givenname: Shixuan surname: Liu fullname: Liu, Shixuan – sequence: 2 givenname: Tao surname: Yuan fullname: Yuan, Tao – sequence: 3 givenname: Shuoning surname: Song fullname: Song, Shuoning – sequence: 4 givenname: Shi surname: Chen fullname: Chen, Shi – sequence: 5 givenname: Linjie surname: Wang fullname: Wang, Linjie – sequence: 6 givenname: Yong surname: Fu fullname: Fu, Yong – sequence: 7 givenname: Yingyue surname: Dong fullname: Dong, Yingyue – sequence: 8 givenname: Yan surname: Tang fullname: Tang, Yan – sequence: 9 givenname: Weigang surname: Zhao fullname: Zhao, Weigang |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34852815$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk9v1DAQxSNURP_AF-CAInHhkmI7seNwQKpWbamoxKV3y7Enu1458WIni_bEV2fSLdVuhVAOice_95wZv_PsZAgDZNl7Si4pleJzoqwhrCCMFoTIpiz4q-yMVjUrhGTlycH3aXae0poQWktG3mSnZSU5k5SfZb9v_WRCgryHUbfBO5Nbl0K0EHM35N-9G6ADP-Iy7QYbQw9fcp1HGGNIGzCj20KuB-13yaVZofPkhqWHfLFCKRqvkHOj9kjZ3Dt00uMUAS22Dn69zV532id49_S-yB5urh8W34r7H7d3i6v7wnBRjoWFCoBbY7RmlWxr3pZVLbQsrSQ1qSgzpu6ga7URsmkoE4Jq02loJTfc0vIiu9vb2qDXahNdr-NOBe3UYyHEpdJxdMaDogyg5QJKAlDx1rQ1KXGETVljuasIen3de22mtgdrYBij9kemxzuDW6ll2Cop0IjNP_PpySCGnxOkUfUuGfBeDxCmpJggXBCCnSD68QW6DlPEcc8UpSXecHVALTU24IYu4LlmNlVXAk9tGBccqct_UPhY6J3BaHUO60eCD4eNPnf4Nz0IsD1gMAwpQveMUKLmiKp9RBVGVD1GVM0i-UJkMB6jC_OwnP-f9A9djOxY |
CitedBy_id | crossref_primary_10_2147_DMSO_S498230 crossref_primary_10_3390_nu14102107 crossref_primary_10_3390_biom13121759 crossref_primary_10_1016_j_beem_2022_101654 |
Cites_doi | 10.1111/jdi.13113 10.2337/dc06-0651 10.1111/j.1743-6109.2010.01991.x 10.2337/diacare.22.9.1462 10.1007/s40618-017-0619-9 10.1161/01.CIR.0000111245.75752.C6 10.2169/internalmedicine.31.917 10.1111/j.1651-2227.2011.02233.x 10.1210/jc.2014-2780 10.1111/cen.12664 10.1210/jc.2005-1077 10.1007/s12020-015-0613-y 10.2169/internalmedicine.35.396 10.1530/eje.1.02166 10.1385/ENDO:27:1:011 10.1210/er.2017-00212 10.1097/MED.0000000000000154 10.1016/j.fertnstert.2012.07.1122 10.1507/endocrj.49.523 10.1210/jc.2012-2382 10.1007/s12020-018-1584-6 10.1210/jc.2005-0697 10.1111/j.1651-2227.2011.02161.x 10.1056/NEJMoa0911101 10.1677/joe.0.0350169 10.1210/jcem.85.7.6661 10.2337/dc13-2845 10.2169/internalmedicine.41.842 10.1111/andr.12275 10.1111/bju.12037 10.1097/MD.0000000000017342 10.2169/internalmedicine.48.1985 10.1530/EC-18-0031 10.1016/j.metabol.2017.09.017 10.1016/j.urology.2008.01.051 10.3803/EnM.2016.31.4.598 10.1155/2019/9616125 10.1001/archinte.1966.00290160014004 10.1016/j.diabet.2011.01.002 10.1210/jcem-29-8-1062 10.1159/000090327 10.1001/jama.2015.10029 10.2337/dc19-S002 10.2337/dc10-2339 10.1007/BF00280883 10.1016/j.ijcard.2012.09.215 10.1210/jc.2016-2904 10.1007/s11892-019-1197-3 |
ContentType | Journal Article |
Copyright | 2021. The Author(s). COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2021 |
Copyright_xml | – notice: 2021. The Author(s). – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7TK 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12902-021-00893-5 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1472-6823 |
EndPage | 10 |
ExternalDocumentID | oai_doaj_org_article_12eeb56e30ee45bcb703823937eb5f40 PMC8638221 A686392565 34852815 10_1186_s12902_021_00893_5 |
Genre | Journal Article Review |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ TR2 TUS UKHRP W2D WOQ WOW XSB ~8M -A0 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF NPM PMFND 7QP 7TK 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c563t-de4ee5dccaa248b75b3476a83d8070412cc7fefbac689912661acfaeb85c5d13 |
IEDL.DBID | 7X7 |
ISSN | 1472-6823 |
IngestDate | Wed Aug 27 01:29:57 EDT 2025 Thu Aug 21 18:42:38 EDT 2025 Thu Jul 10 19:13:29 EDT 2025 Fri Jul 25 06:22:46 EDT 2025 Tue Jun 17 21:51:20 EDT 2025 Tue Jun 10 20:24:44 EDT 2025 Thu Jan 02 22:55:48 EST 2025 Tue Jul 01 01:37:14 EDT 2025 Thu Apr 24 22:52:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Klinefelter syndrome Insulin resistance Hyperglycemia Hypoglycemic therapy Diabetes mellitus |
Language | English |
License | 2021. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c563t-de4ee5dccaa248b75b3476a83d8070412cc7fefbac689912661acfaeb85c5d13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2611314749?pq-origsite=%requestingapplication% |
PMID | 34852815 |
PQID | 2611314749 |
PQPubID | 44656 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_12eeb56e30ee45bcb703823937eb5f40 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8638221 proquest_miscellaneous_2605600689 proquest_journals_2611314749 gale_infotracmisc_A686392565 gale_infotracacademiconefile_A686392565 pubmed_primary_34852815 crossref_primary_10_1186_s12902_021_00893_5 crossref_citationtrail_10_1186_s12902_021_00893_5 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-12-01 |
PublicationDateYYYYMMDD | 2021-12-01 |
PublicationDate_xml | – month: 12 year: 2021 text: 2021-12-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC endocrine disorders |
PublicationTitleAlternate | BMC Endocr Disord |
PublicationYear | 2021 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | MZ Bardsley (893_CR29) 2011; 100 A Menke (893_CR40) 2015; 314 SJ Han (893_CR20) 2016; 31 D Kapoor (893_CR49) 2006; 154 D Pasquali (893_CR26) 2013; 168 M Gotoh (893_CR33) 2002; 49 G Corona (893_CR44) 2011; 8 A Bojesen (893_CR11) 2006; 91 B Antuna-Puente (893_CR18) 2011; 37 D Pei (893_CR47) 1998; 97 KA Groth (893_CR53) 2013; 98 HJ Kim (893_CR35) 2006; 65 C Wang (893_CR43) 2011; 34 M Matsuda (893_CR17) 1999; 22 FC Wu (893_CR42) 2010; 363 M Grossmann (893_CR52) 2015; 83 AS Herlihy (893_CR3) 2015; 22 M Jiang-Feng (893_CR6) 2012; 98 K Isobe (893_CR37) 1992; 31 K Tojo (893_CR38) 1996; 35 S Hara (893_CR31) 1970; 62 KW Lee (893_CR48) 1998; 13 EJ Gianatti (893_CR51) 2014; 37 L Wei (893_CR30) 2019; 98 893_CR36 KL Becker (893_CR25) 1966; 118 893_CR34 J Nielsen (893_CR9) 1969; 29 DR Matthews (893_CR19) 1985; 28 MJ O'Connor (893_CR2) 2019; 19 AE Calogero (893_CR7) 2017; 40 IM Jackson (893_CR24) 1966; 35 K Ota (893_CR23) 2002; 41 SM Davis (893_CR28) 2017; 102 A Katz (893_CR16) 2000; 85 CH Gravholt (893_CR5) 2011; 100 SM Grundy (893_CR15) 2004; 109 J Mirouze (893_CR41) 1966; 14 WS Tan (893_CR50) 2013; 111 F Panimolle (893_CR46) 2016; 52 Z Yesilova (893_CR21) 2005; 27 S Davis (893_CR27) 2016; 4 M Zitzmann (893_CR45) 2015; 100 AJ Swerdlow (893_CR12) 2005; 90 H Falhammar (893_CR22) 2018; 7 I Yoshiuchi (893_CR32) 2006; 29 M Ayli (893_CR39) 2009; 48 T Ishikawa (893_CR4) 2008; 71 893_CR13 893_CR14 GA Kanakis (893_CR1) 2018; 86 CH Gravholt (893_CR8) 2018; 39 893_CR10 |
References_xml | – ident: 893_CR36 doi: 10.1111/jdi.13113 – volume: 29 start-page: 1981 issue: 8 year: 2006 ident: 893_CR32 publication-title: Diabetes Care doi: 10.2337/dc06-0651 – volume: 14 start-page: 57 issue: 2 year: 1966 ident: 893_CR41 publication-title: Diabete – volume: 8 start-page: 272 issue: 1 year: 2011 ident: 893_CR44 publication-title: J Sex Med doi: 10.1111/j.1743-6109.2010.01991.x – volume: 22 start-page: 1462 issue: 9 year: 1999 ident: 893_CR17 publication-title: Diabetes Care doi: 10.2337/diacare.22.9.1462 – volume: 40 start-page: 705 issue: 7 year: 2017 ident: 893_CR7 publication-title: J Endocrinol Investig doi: 10.1007/s40618-017-0619-9 – volume: 109 start-page: 433 issue: 3 year: 2004 ident: 893_CR15 publication-title: Circulation doi: 10.1161/01.CIR.0000111245.75752.C6 – volume: 31 start-page: 917 issue: 7 year: 1992 ident: 893_CR37 publication-title: Intern Med doi: 10.2169/internalmedicine.31.917 – volume: 100 start-page: 871 issue: 6 year: 2011 ident: 893_CR5 publication-title: Acta Paediatr doi: 10.1111/j.1651-2227.2011.02233.x – volume: 100 start-page: E518 issue: 3 year: 2015 ident: 893_CR45 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2014-2780 – volume: 83 start-page: 344 issue: 3 year: 2015 ident: 893_CR52 publication-title: Clin Endocrinol (Oxf) doi: 10.1111/cen.12664 – volume: 90 start-page: 6516 issue: 12 year: 2005 ident: 893_CR12 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-1077 – volume: 52 start-page: 157 issue: 1 year: 2016 ident: 893_CR46 publication-title: Endocrine doi: 10.1007/s12020-015-0613-y – volume: 35 start-page: 396 issue: 5 year: 1996 ident: 893_CR38 publication-title: Intern Med doi: 10.2169/internalmedicine.35.396 – volume: 154 start-page: 899 issue: 6 year: 2006 ident: 893_CR49 publication-title: Eur J Endocrinol doi: 10.1530/eje.1.02166 – volume: 27 start-page: 11 issue: 1 year: 2005 ident: 893_CR21 publication-title: Endocrine doi: 10.1385/ENDO:27:1:011 – volume: 39 start-page: 389 issue: 4 year: 2018 ident: 893_CR8 publication-title: Endocr Rev doi: 10.1210/er.2017-00212 – volume: 22 start-page: 224 issue: 3 year: 2015 ident: 893_CR3 publication-title: Curr Opin Endocrinol Diabetes Obes doi: 10.1097/MED.0000000000000154 – volume: 98 start-page: 1331 issue: 5 year: 2012 ident: 893_CR6 publication-title: Fertil Steril doi: 10.1016/j.fertnstert.2012.07.1122 – volume: 49 start-page: 523 issue: 4 year: 2002 ident: 893_CR33 publication-title: Endocr J doi: 10.1507/endocrj.49.523 – volume: 98 start-page: 20 issue: 1 year: 2013 ident: 893_CR53 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2012-2382 – ident: 893_CR10 doi: 10.1007/s12020-018-1584-6 – volume: 97 start-page: 534 issue: 8 year: 1998 ident: 893_CR47 publication-title: J Formos Med Assoc – volume: 91 start-page: 1254 issue: 4 year: 2006 ident: 893_CR11 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2005-0697 – volume: 100 start-page: 866 issue: 6 year: 2011 ident: 893_CR29 publication-title: Acta Paediatr doi: 10.1111/j.1651-2227.2011.02161.x – volume: 363 start-page: 123 issue: 2 year: 2010 ident: 893_CR42 publication-title: N Engl J Med doi: 10.1056/NEJMoa0911101 – volume: 35 start-page: 169 issue: 2 year: 1966 ident: 893_CR24 publication-title: J Endocrinol doi: 10.1677/joe.0.0350169 – volume: 85 start-page: 2402 issue: 7 year: 2000 ident: 893_CR16 publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.85.7.6661 – volume: 37 start-page: 2098 issue: 8 year: 2014 ident: 893_CR51 publication-title: Diabetes Care doi: 10.2337/dc13-2845 – volume: 41 start-page: 842 issue: 10 year: 2002 ident: 893_CR23 publication-title: Intern Med doi: 10.2169/internalmedicine.41.842 – volume: 4 start-page: 1169 issue: 6 year: 2016 ident: 893_CR27 publication-title: Andrology doi: 10.1111/andr.12275 – volume: 111 start-page: 1130 issue: 7 year: 2013 ident: 893_CR50 publication-title: BJU Int doi: 10.1111/bju.12037 – volume: 98 start-page: e17342 issue: 39 year: 2019 ident: 893_CR30 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000017342 – volume: 48 start-page: 1681 issue: 18 year: 2009 ident: 893_CR39 publication-title: Intern Med doi: 10.2169/internalmedicine.48.1985 – volume: 7 start-page: 466 issue: 3 year: 2018 ident: 893_CR22 publication-title: Endocr Connect doi: 10.1530/EC-18-0031 – volume: 86 start-page: 135 year: 2018 ident: 893_CR1 publication-title: Metabolism doi: 10.1016/j.metabol.2017.09.017 – volume: 71 start-page: 1109 issue: 6 year: 2008 ident: 893_CR4 publication-title: Urology doi: 10.1016/j.urology.2008.01.051 – volume: 31 start-page: 598 issue: 4 year: 2016 ident: 893_CR20 publication-title: Endocrinol Metab (Seoul) doi: 10.3803/EnM.2016.31.4.598 – ident: 893_CR34 doi: 10.1155/2019/9616125 – volume: 118 start-page: 314 issue: 4 year: 1966 ident: 893_CR25 publication-title: Arch Intern Med doi: 10.1001/archinte.1966.00290160014004 – volume: 13 start-page: 495 year: 1998 ident: 893_CR48 publication-title: J Korean Soc Endocrinol – volume: 37 start-page: 179 issue: 3 year: 2011 ident: 893_CR18 publication-title: Diabetes Metab doi: 10.1016/j.diabet.2011.01.002 – volume: 29 start-page: 1062 issue: 8 year: 1969 ident: 893_CR9 publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-29-8-1062 – volume: 65 start-page: 14 issue: 1 year: 2006 ident: 893_CR35 publication-title: Horm Res doi: 10.1159/000090327 – volume: 314 start-page: 1021 issue: 10 year: 2015 ident: 893_CR40 publication-title: Jama doi: 10.1001/jama.2015.10029 – ident: 893_CR13 doi: 10.2337/dc19-S002 – volume: 34 start-page: 1669 issue: 7 year: 2011 ident: 893_CR43 publication-title: Diabetes Care doi: 10.2337/dc10-2339 – volume: 28 start-page: 412 issue: 7 year: 1985 ident: 893_CR19 publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 168 start-page: 754 issue: 2 year: 2013 ident: 893_CR26 publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2012.09.215 – volume: 102 start-page: 176 issue: 1 year: 2017 ident: 893_CR28 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2016-2904 – volume: 62 start-page: 42 issue: 1 year: 1970 ident: 893_CR31 publication-title: J Natl Med Assoc – ident: 893_CR14 – volume: 19 start-page: 71 issue: 9 year: 2019 ident: 893_CR2 publication-title: Curr Diab Rep doi: 10.1007/s11892-019-1197-3 |
SSID | ssj0017820 |
Score | 2.2625542 |
SecondaryResourceType | review_article |
Snippet | We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia.
This is a... Background We aimed to investigate the clinical characteristics and islet [beta]-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia.... We aimed to investigate the clinical characteristics and islet [beta]-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. This is a... Background We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia. Methods... We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and hyperglycemia.BACKGROUNDWe aimed... Abstract Background We aimed to investigate the clinical characteristics and islet β-cell function in patients with Klinefelter syndrome (KS) and... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 239 |
SubjectTerms | Adolescent Analysis Beta cells Blood glucose Blood pressure Blood sugar Body mass index Child China - epidemiology Diabetes Diabetes mellitus Diabetes Mellitus - epidemiology Dyslipidemia Dyslipidemias - epidemiology Electronic medical records Glucose Glucose metabolism Glucose Metabolism Disorders - epidemiology Glucose tolerance Glucose tolerance tests Health aspects Homeostasis Hospitals Humans Hyperglycemia Hyperglycemia - epidemiology Hypertension Hypertension - epidemiology Hypoglycemia Hypoglycemic therapy Insulin Insulin Resistance Insulin secretion Insulin-Secreting Cells - physiology Klinefelter syndrome Klinefelter Syndrome - epidemiology Klinefelter Syndrome - physiopathology Klinefelter's syndrome Laboratories Literature reviews Male Medical records Medical research Medicine, Experimental Metabolic disorders Metabolic syndrome Pancreatic beta cells Patients Population Prediabetic state Prediabetic State - epidemiology Retrospective Studies Secretion Values Young Adult |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na90wDDejh7LL2PeydcWDwQ7D9Dm2E7_e2rKubHSnDnoz_lDog7e88pqe969XSpzwwmC77BrLiW3JlhRLPzH2Eco6aaVqUdugBepbLbxXUoQmxWYZF41eUoLz5Y_q4qf-dm2ud0p9UUzYAA88LNyRLAGCqUAtALQJMaCIWsLtqvFxo3tvHXXe6Ezl-wNCgRtTZGx1dEd_W0pB4Qio85ZKmJka6tH6_zyTd5TSPGByRwOdP2VPsunIT4YhP2OPoH3O9i_z5fgL9vvrEH7Of0GHrF2vIk8ZW5OvWv6dDMoG6HacjzgFx9zzLXTbzZhwyX0GKaEentOPhDVwKrIN-OKbXGQEqRJfT4DMfMh_ecmuzr9cnV2IXF9BRFOpTiTQACYhD32pbahNULquvFXJ4kGgZRlj3UATfKzQK5Okyn1sPARroklSvWJ77aaFN4wrWQWJTXIRGu1NCBrtiqQ8oHOEFmIomBxX28WMPU4lMNau90Fs5QYOOeSQ6znkTME-T31uB-SNv1KfEhMnSkLN7h-gLLksS-5fslSwTyQCjvY2Di_6nKKAkySULHdSWTTo0EjEzx3MKHFPxnnzKEQunwl3Dn1VqaSu9bJgH6Zm6klxbi1s7olmQSYornfBXg8yN01JaWtKK_Hl9UwaZ3Oet7Srmx4xHMeFhqB8-z8W6R17XNJG6kN6Dthet72H92iYdeGw34MPZeU3Dg priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9cwEA9zgvgi_rZzSgTBB6l-0yRtvoLIFOdQvj5tsLeQpNftC7Vf13WgT_7r3rVpXXHstUnaJHeXu2vuPsfYS8iKUklZpIXxKkV9q1LnpEh9VYZqGRaVWlKC8-p7fnCkvh7r4y02ljuKG3h-pWtH9aSO2vrNr7PfH1Dg3_cCb_K35_QvJUsp2AA12lKm-ga7iZqpIEFdqX-3CoQNNybOXDluppx6DP__T-pLqmoeRnlJL-3fZXeiQcn3Bg64x7aguc9ureKV-QP258sQlM5_QIcEr9eBlxFxk68b_o3MzArozpyP6AXvuOMtdO1mTMPkLkKX0AjH6fdCDZxKbwO--DSWHsFeJa8nmGY-ZMU8ZIf7nw8_HaSx6kIadC67tAQFoEukrMuU8YX2UhW5M7I0eDwokYVQVFB5F3L01QQpeBcqB97ooEshH7HtZtPAE8alyL3AJrHwlXLae4XWRikdoMuEdqNPmBh324aISE6FMWrbeyYmtwOFLFLI9hSyOmGvpzE_BzyOa3t_JCJOPQlLu3-waU9sFE0rMgCvc5ALAKV98HgIGkKGK_BxpRYJe0UsYIkHcXrBxcQFXCRhZ9m93KCZh6Yjfm531hMlNcybRyayI6Nb9GCFFKpQy4S9mJppJEW_NbC5oD4LMkxxvxP2eOC5aUlSGZ0ZgS8vZtw4W_O8pVmf9jjiOC80D8XO9dN6ym5nJCJ9CM8u2-7aC3iGhljnn_fS9Rcp7jGl priority: 102 providerName: Scholars Portal |
Title | Glucose metabolic disorder in Klinefelter syndrome: a retrospective analysis in a single Chinese hospital and literature review |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34852815 https://www.proquest.com/docview/2611314749 https://www.proquest.com/docview/2605600689 https://pubmed.ncbi.nlm.nih.gov/PMC8638221 https://doaj.org/article/12eeb56e30ee45bcb703823937eb5f40 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96B-KL-O3quUQQfJByTZO0WV_kVu48lD3kOGHxJSTp1FtY23N379l_3Zk2rVeEe-lDk7RJZjIzSWZ-w9hbyIpSSVkkhfEqQX2rEuekSHxVhmoW0krNKMB5cZaffldflnoZD9y20a2yl4mtoC6bQGfkh2jpCylUoWYfr34nlDWKbldjCo27bJ-gy8ilq1gOGy5BWHB9oIzJD7d05pIl5JSAmm8mEz1SRi1m__-S-YZqGrtN3tBDJw_Zg2hA8qOO4o_YHagfs3uLeEX-hP353Dmh81-wQwKvV4GXEWGTr2r-lczKCuiOnPdoBR-44xvYbZo-7JK7CFVCLRyn44Q1cEq1Dfjhy5hqBGuVfD3AMvMuCuYpuzg5vvh0msQsC0nQudwlJSgAXSIlXaaML7SXqsidkaVBcaBEFkJRQeVdyHFvJkihu1A58EYHXQr5jO3VTQ0vGJci9wKLROor5bT3Cq2LUjrALRLaiX7CRD_bNkQEckqEsbbtTsTktqOQRQrZlkJWT9j7oc1Vh79xa-05EXGoSdjZ7Ytm89PGpWhFBuB1DjIFUNoHj0LPEBJcga8rlU7YO2IBSyscuxdcDFTAQRJWlj3KDZp1aCri7w5GNXFlhnFxz0Q2Soat_cfHE_ZmKKaW5O1WQ3NNdVIyRHG-J-x5x3PDkKQyOjMCP16MuHE05nFJvbpsccOxX2gOipe3d-sVu5_REmlddg7Y3m5zDa_R8Nr5abu6pmx_fnz27XzaHl_gc6EMPs_nP_4CpCoy9Q |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxELZKKgEXxLMEChgJxAGtGq_tXQcJoRZaUtJECBWpN8v2ztJIYVOSVIgTv4j_yMy-6Aqpt17Xj7U945mxPfMNYy8gTjMlZRqlxqsI9a2KnJMi8nkW8mEY5GpIAc6TaTL6qj6d6JMN9qeJhSG3ykYmloI6WwS6I99BS19IoVI1fHf2I6KsUfS62qTQqNhiDL9-4pFt9fbwA9L3ZRwf7B-_H0V1VoEo6ESuowwUgM5w5C5WxqfaS5UmzsjMIPsrEYeQ5pB7FxI8iwhSYC7kDrzRQWdCYrfX2KaSeJLpsc29_ennL-2zBYHPNZE5JtlZ0SVPHJEXBKraoYx0R_uVSQL-VwUXdGHXT_OC4ju4zW7VFivfrVjsDtuA4i67Pqnf5O-x3x8rr3f-HdbIUfNZ4FkN6clnBR-THZsDPcrzBh7hDXd8Cevloonz5K7GRqEWjtP9xRw45fYG7Pi0zm2CtTI-b3GgeRV2c58dXwUBHrBesSjgIeNSJF5gkRj4XDntvUJzJpMO8EyGhqnvM9Gstg015Dll3pjb8uhjEltRyCKFbEkhq_vsddvmrAL8uLT2HhGxrUlg3eWHxfKbrfe-FTGA1wnIAYDSPniUsoag51L8nKtBn70iFrAkUnB4wdWREThJAueyu4lBOxJtU_zddqcmioLQLW6YyNaiaGX_bZw-e94WU0tyrytgcU51BmT54nr32VbFc-2UpDI6NgI7Tzvc2Jlzt6SYnZZA5TgutD_Fo8uH9YzdGB1PjuzR4XT8mN2MabuU_kLbrLdensMTtPrW_mm91zizV7y7_wKi3W36 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glucose+metabolic+disorder+in+Klinefelter+syndrome%3A+a+retrospective+analysis+in+a+single+Chinese+hospital+and+literature+review&rft.jtitle=BMC+endocrine+disorders&rft.au=Liu%2C+Shixuan&rft.au=Yuan%2C+Tao&rft.au=Song%2C+Shuoning&rft.au=Chen%2C+Shi&rft.date=2021-12-01&rft.pub=BioMed+Central&rft.eissn=1472-6823&rft.volume=21&rft.spage=1&rft_id=info:doi/10.1186%2Fs12902-021-00893-5 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6823&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6823&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6823&client=summon |